Top 5 Art VC Funds &amp; Investors in Germany (May 2026)

Redalpine is one of the leading European Venture Capital investors with a focus on highly scalable start-ups. The firm's mission is to help talented entrepreneurs turn an ambitious vision into reality by providing money, experience, coaching, and a strong network. The firm is focused on seed and early-stage investments in disruptivetechnologies in tech and health tech. Redalpine launched its first fund (Redalpine Capital I) in 2007, following the founding partners’ track record of some excellent trade sales and IPOs as serial entrepreneurs and professional angel investors. In 2021 Redalpine closed its sixth fund (Redalpine Capital VI) and currently has approx. USD 1 Billion in AUM. The highly interdisciplinary Redalpine team supports more than 70 portfolio companies with operational and sector-specific expertise and with a rich international network.Redalpine started with its first fund (Redalpine Capital I) in 2007 based on the track-record of some excellent trade-sales and IPOs as serial entrepreneurs and professional angel investors. Redalpine sucessfully launched Redalpine Capital II in 2012 and Redalpine Capital III in 2016. The funds are registered in Luxemburg and backed by dozens of experienced entrepreneurs and investors representing various countries, and a broad range of industries.

Investment focus

Industry: Software, Biotechnology, Health Care
Stage:Series A, Seed, Series B
Geography: Germany, Switzerland, United Kingdom

Investor stats

Total investments: 130
Round size: Seed $800k–$6.7M; Series A $2M–$24M; Series B $12M–$59M
Lead/follow: 40% lead, 60% follow
Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

Zealy — A simple, fun & creative way to join trendy communities, make an impact and earn rewards.
Genialis — Genialis is a precision medicine data science company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at the intersection of clinical and translational medicine and drug discovery. Genialis is trusted by biopharma and big pharma alike, to validate targets, predict biomarkersand optimally position novel drugs. Together, Genialis and its partners are bringing improved solutions to drug discovery to change people's lives.
Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.

Show all investments...

Piton Capital is a venture capital and growth equity firm headquartered in London, United Kingdom. Piton focuses exclusively on network effects businesses (marketplaces, exchanges and platforms) as this provide one of the few moats or forms of defensibility to achieve dominance. There are several forms of great network effects businesses thataren’t marketplaces that include data network effects (including machine learning and AI), businesses that rely on user generated content, as well as SaaS businesses with the potential to layer network effects around it. The firm is a stage and style-agnostic and seeks to invest from seed to late stage (€200k to €15m).

Investment focus

Industry: E-Commerce, Marketplace, Internet
Stage:Series A, Series B
Geography: Germany, United Kingdom, France

Investor stats

Total investments: 103
Round size: Series A $1.7M–$8M; Series B $5.4M–$51M
Lead/follow: 23% lead, 77% follow
Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

enmacc — The enmacc OTC platform is a energy trading platform for the future of the global energy markets. We are building a next-generation trading platform, powered digital RFQ technology, that will help you to trade smarter, faster and better.
Patient 21 — Patient21 believes that the doctor-patient connection is the cornerstone to good healthcare and that it is their responsibility to remove any impediments to it. They think that the greatest healthcare necessitates cross-specialty collaboration and universal data access. Always with one purpose in mind: to help patients and physicians make betterdecisions.In comparison to today's linked world, healthcare appears to be trapped in the past. It continues to use the same analogue and isolated processes. Patient21 is on a quest to usher healthcare into the twenty-first century. They use data to help doctors give the most personalized treatments possible. And, with the help of their professional network, they are attempting to give a comprehensive perspective of their client's health.
Ferryhopper — Book cheap ferry tickets to over 500 destinations worldwide! Join 2 million travelers as you compare ferry companies, find deals, and book ferries.

Show all investments...

Vorwerk Ventures is an independent €150m Venture Capital Fund grown out of the Vorwerk Group in late 2019 and defines itself through a strong commitment towards consumer-facing digital businesses. Our unique direct selling experience in addition to an outstanding track record in Venture Capital provides added value for forward-thinkingentrepreneurs. Headquartered in Berlin Germany, we currently have more than €250m in assets under management and are constantly on the look-out for promising opportunities starting with Seed/Series A investments of €1m to €10m and ensuring continuous support reserving up to €15m for upcoming financing rounds. An outstanding founding team, an existing market presence and a well-defined exit strategy framed by a consumer-centric business model are key requirements to us when it comes to making an investment decision.

Investment focus

Industry: E-Commerce, Health Care, Food and Beverage
Stage:Series A, Seed, Series B
Geography: Germany, United Kingdom, United States

Investor stats

Total investments: 70
Round size: Seed $3.2M–$11M; Series A $1.1M–$24M; Series B $10M–$86M
Lead/follow: 34% lead, 66% follow
Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

Sunhero — Sunhero delivers custom-built solar panel solutions. Sunhero offers consumers a hassle-free method of installing customised photovoltaic solar systems on their homes, be that either purchasing outright or renting for a 20 year period.
Rex — Veterinary practices you always wanted
Planted Foods — Planted is an ETH Spinoff that uses cutting-edge technology to turn four natural ingredients into plant-based meat that mimics the taste, texture, and mouthfeel of traditional animal meat. It takes only the best raw materials from plants and creates that tasty, nutritious, high-protein, and juicy planted that the customers love.It was founded in2019 and is headquartered in Zürich, Switzerland.

Show all investments...

Since 1999, Acton Capital invests in tech-enabled business models to create value for the long run. We support world-class teams on their way to market leadership.

Investment focus

Industry: E-Commerce, Internet, Software
Stage:Series A, Series B
Geography: Germany, Canada, United Kingdom

Investor stats

Total investments: 111
Round size: Series A $3.2M–$13M; Series B $6M–$53M
Lead/follow: 43% lead, 57% follow
Last fund: May invest from a new fund soon — raised $215M in 2019

Portfolio highlights

Klaus — Hypergrowth companies use Klaus to run an effective customer service QA process, coach agents, and boost retention.
Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
ECO Group — Eco is a supplier of consumer products. They create structures for increased growth and profitability within the group companies.

Show all investments...